sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
2020-2025 Global Antiandrogen Monotherapy Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)

2020-2025 Global Antiandrogen Monotherapy Market Report - Production and Consumption...

Home / Categories / Information & Communications Technology
2020-2025 Global Antiandrogen Monotherapy Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
2020-2025 Global Antiandrogen Monotherapy Market...
Report Code
RO9/125/41308

Publish Date
25/May/2021

Pages
104
PRICE
$ 3360/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 5040/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 6720/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..

This report elaborates the market size, market characteristics, and market growth of the Antiandrogen Monotherapy industry, and breaks down according to the type, application, and consumption area of Antiandrogen Monotherapy. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Antiandrogen Monotherapy in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Antiandrogen Monotherapy market covered in Chapter 13:
Astellas Pharma Inc.
Genentech Inc.
Abbott Laboratories
Takeda Pharmaceutical Company Limited
Amgen Inc
Sanofi SA
OSI Pharmaceuticals, Inc.
Novartis AG
ANI Pharmaceuticals, Inc.
GlaxoSmithKline Plc
Progenics Pharmaceuticals, Inc.
Pfizer Inc.
Bristol-Myers Squibb Company
AstraZeneca Plc
F. Hoffmann-La Roche Ltd.
ALZA Corporation

In Chapter 6, on the basis of types, the Antiandrogen Monotherapy market from 2015 to 2025 is primarily split into:
Steroidal
Nonsteroidal

In Chapter 7, on the basis of applications, the Antiandrogen Monotherapy market from 2015 to 2025 covers:
Prostate Cancer
Benign Prostatic Hyperplasia
Hirsutism
Hyperandrogenism
Others

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com